Stay updated on Sub-Lingual Dexmedetomidine in Agitation Clinical Trial
Sign up to get notified when there's something new on the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page.

Latest updates to the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange Detected- Locations are consolidated under a single Locations section listing Florida, Massachusetts, Michigan, and New Jersey; the previous location sections and the HHS Vulnerability Disclosure link were removed, and the revision label updated to v3.3.3.SummaryDifference0.5%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe Publications section wording was updated to clarify that PubMed-sourced publications may not pertain to the study, and the revision label was updated to v3.3.2.SummaryDifference0.1%

- Check51 days agoChange DetectedThe government funding/operating status notice on the page has been removed.SummaryDifference0.3%

- Check65 days agoChange DetectedThere are no substantive updates detected on the Study Details page for NCT04251910. The trial design, eligibility criteria, and outcome measures appear unchanged from the previous version.SummaryDifference0.4%

- Check94 days agoChange DetectedUpgrade to v3.2.0 with a government operating-status notice and links to status pages; removes the previous v3.1.0 reference.SummaryDifference3%

- Check101 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%

Stay in the know with updates to Sub-Lingual Dexmedetomidine in Agitation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sub-Lingual Dexmedetomidine in Agitation Clinical Trial page.